ArticleJournal of the West African College of Surgeons
MANAGEMENT OF PROSTATE CANCER IN ACCRA, GHANA.
Article in Journal of the West African College of Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 18 citations in OpenAlex.
- Multiparametric MRI findings, PI-RADS scores, and gleason scores in prostate cancer patients at Kumasi, Ghana: a cross-sectional analysis.BMC medical imaging · 2026Article
- Barriers to orthodox medical care of prostate cancer in Ghana.Scientific reports · 2025Article
- 'Beyond Treatment': Clinical and psychosocial predictors of health-related quality of life of patients with prostate cancer.SAGE open medicine · 2025Article
- Case Report: Atypical prostate cancer presentation: rectal bleeding, pain, and psoriasiform dermatitis.Frontiers in oncology · 2025Article
- Article
- Perceptions of prostate cancer patients undergoing definitive radiotherapy on the impact of prostate cancer and radiation therapy on male sexuality.Ecancermedicalscience · 2024Article
- Journeying together: spousal experiences with prostate cancer in Ghana.Ecancermedicalscience · 2024Article
- Prostate cancer knowledge and barriers to screening among men at risk in northern Tanzania: A community-based study.Cancer treatment and research communications · 2024Article
- A critical review and analysis of the context, current burden, and application of policy to improve cancer equity in Ghana.International journal for equity in health · 2023Review
- Biochemical outcome after curative treatment for localized prostate cancer with external beam radiotherapy: a cross-sectional study.Ecancermedicalscience · 2023Article
- Incidence and mortality of cancer in the Volta Region of Ghana.Experimental biology and medicine (Maywood, N.J.) · 2020Article
- Management of Advanced and Metastatic Prostate Cancer: A Need for a Sub-Saharan Guideline.Journal of oncology · 2019Review
- The Trends, Clinicopathological Features, and Treatment Outcomes of Patients with Prostate Cancer in Lokoja, Nigeria.Journal of the West African College of SurgeonsArticle
- Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer.World journal of nuclear medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 1 institution in 1 country.
Funding
Abstract
introductionAfricans living with prostate cancer in Africa face problems of early diagnosis and appropriate treatment.
aimTo study the clinical incidence of prostate cancer, risk factors, TNM stage, their management and outcomes.
methodsA prospective study of Prostate Cancer cases managed at Korle Bu Teaching Hospital and hospitals in Accra, diagnosed by history, abnormal PSA/DRE, physical examination and histologically confirmed by biopsy from 2004 to 2013 was carried out. The cases were TNM staged and managed by approved protocol.
resultsThere were 669 cases with a mean age 70±0.045SE years, median Gleason Score of 7, organ confined Prostate Cancer(PC) in 415(62%), locally advanced in 167(25%) and metastatic Prostate Cancer in 87(13%) cases. The cases were followed for median of 10 months to ≥ 84 months. Organ confined cases were managed by: Radical Prostatectomy (RP) 92 (13.8%) with a mortality of 0.3%; brachytherapy 70 (10.5%) with a mortality of 0.1% and External Beam Radiotherapy (EBRT) 155 (23%) with a mortality 0.7%. In all, 98 men constituting (14.1%) cases with a mean age of 75+0.25SE years, life expectancy <10 years were treated by hormonal therapy with a mortality of 1.7%. Twenty cases who were for active surveillance (GS6), PSA <10ng/ml, life expectancy <10 years later all opted for EBRT. Locally advanced cases 25% all had neoadjuvant hormonal therapy then Brachytherapy in 3 (0.4%) mortality 0.15% and EBRT in 64 (9.5%), mortality 0.59%. Hormonal therapy was given in 100 (15%) locally advanced cases, mortality 5%. Metastatic prostate cancer cases (13%) were managed by hormonal therapy, mortality 6%.
conclusionImproved facilities and dedicated skilled teams led to a significant rise in proportion of organ confined Prostate Cancer from 15.3% to 62% curable by Radical Prostatectomy, brachytherapy or EBRT with longer disease free survival.
Indexed as
Identifiers
29181364PMC5667721W3024214884What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.